v3.26.3
License and Collaboration Agreements - Additional Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 31 Months Ended
Mar. 01, 2024
USD ($)
Feb. 29, 2024
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2026
USD ($)
performance_obligation
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
Dec. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Feb. 07, 2024
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Accounts receivable, net       $ 375,089     $ 375,089   $ 375,089 $ 139,444 [1]    
Revenue       353,171 $ 120,700   791,362 $ 347,898        
Deferred revenue, current portion       4,744     4,744   4,744 7,190 [1]    
Deferred revenue, net of current portion       8,968     8,968   8,968 13,080 [1]    
License and services revenue                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue       79,314 8,311   $ 89,537 125,441        
Bayer                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue, remaining performance obligation, amount                     $ 135,000  
Number of performance obligations | performance_obligation             2          
Accounts receivable, net       94,200     $ 94,200   94,200 5,000    
Bayer | Seller Parties                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Regulatory and sales milestone payments eligible to receive $ 150,000                      
Revenue, remaining performance obligation, sales milestone payment $ 450,000                      
Bayer | Seller Parties | Collaborative Arrangement                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability, revenue recognized                 285,000      
Bayer | License and services revenue                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability, revenue recognized       200 300   600 1,000        
Notice period for termination of agreement 270 days                      
Contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized         75,000 $ 75,000            
Revenue         9,100     89,400        
Bayer | License and services revenue | Seller Parties                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability $ 135,000                      
Bayer | License                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue, remaining performance obligation, amount                     130,500  
Bayer | Research and Development Services                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability       2,300     2,300   2,300 2,900    
Revenue, remaining performance obligation, amount                     $ 4,500  
Deferred revenue, current portion       800     800   800 800    
Deferred revenue, net of current portion       1,500     1,500   1,500 2,100    
Bayer | Cost of license, services, and royalty revenue                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue       94,400     122,300          
Kyowa Kirin Co., Ltd                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability       9,600     $ 9,600   9,600 14,600    
Notice period for termination of agreement   180 days                    
Revenue, remaining performance obligation, amount   $ 100,000                    
Number of performance obligations | performance_obligation             2          
Deferred revenue, current portion       3,000     $ 3,000   3,000 5,400    
Deferred revenue, net of current portion       6,600     6,600   $ 6,600 $ 9,200    
Kyowa Kirin Co., Ltd | QED Therapeutics, Inc                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability   100,000                    
Regulatory and sales milestone payments eligible to receive   81,400                    
Revenue, remaining performance obligation, upfront payment   100,000                    
Royalty percentage, maximum                       25.00%
Kyowa Kirin Co., Ltd | License and services revenue                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability, revenue recognized       1,400 2,700   4,900 8,500        
Revenue       2,500 3,300   6,500 9,900        
Kyowa Kirin Co., Ltd | License                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue, remaining performance obligation, amount   69,100                    
Kyowa Kirin Co., Ltd | Research and Development Services                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue, remaining performance obligation, amount   $ 30,900                    
Alexion License Agreements | Eidos                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Contract with customer, liability     $ 25,000                  
Alexion License Agreements | License and services revenue                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue       $ 2,800 $ 100   $ 5,900 $ 32,100        
Alexion License Agreements | License and services revenue | Eidos                        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                        
Revenue, remaining performance obligation, regulatory milestone payment     $ 30,000                  
[1] The condensed consolidated balance sheet as of December 31, 2025 is derived from the audited consolidated financial statements as of that date.